Vet Group. business summary
|
|
- Abigayle Paul
- 5 years ago
- Views:
Transcription
1 Vet Group business summary
2 Pets at Home Group overview Standalone vet practices Veterinary Specialist Referral Centres Specialist Referral Centres Pets at Home Group Plc is the UK s leading pet care business; our commitment is to make sure pets and their owners get the very best advice, products and care. In-store vet practices Grooming salons Pet products are available online or from close to 450 Pets at Home superstores, many of which also have vet practices and grooming salons. Pets at Home operates a UK leading small animal veterinary business, with over 460 First Opinion practices located both in our stores and in standalone locations, as well as four Specialist Referral vet hospitals. For more information visit: investors.petsathome.com VIP club: the UK s largest pet loyalty scheme, with pet and purchase data for around 4m customers Retail products in-store or online Vet Group Business Summary 1
3 Business segments Retail Stores / Omnichannel / Grooming services Vet Group First Opinion practices and Specialist Referral centres 804.9m Revenue m 94.1m Underlying EBITDA Revenue m Underlying EBITDA Note: Financials refer to the Financial Year (FY) 2018 ended 29 March Group revenue was 898.9m and Group underlying EBITDA was 123.3m, which includes 5.8m of central costs. 1. Non-underlying items in Retail include 2.7m associated with the closure of Barkers. 2. Non-underlying items in the Vet Group include 1.6m accounting charge for the acquisition of minority stakes owned by vet partners in specialist referral centres, and 0.6m of other expenses. Vet Group Business Summary 2
4 The Pets at Home Vet Group We have the largest branded veterinary business in the UK. This includes over 460 First Opinion practices, operating mainly under the Vets4Pets brand, located in our stores and in standalone locations. These practices deal with all general aspects of small animal veterinary work. We also own four Specialist Referral Centres, which are pet hospitals that handle the most complex veterinary cases. First Opinion practices All aspects of general small animal veterinary work: preventative care, emergency care, sick pet treatment Specialist Referral Centres Internal medicine / Oncology / Orthopaedic surgery / Soft tissue surgery / Neurology and neurosurgery / Diagnostic imaging fee income 41.0m 2 Referral Centre revenue and other veterinary income Specialist Referral Centres 309 in-store 152 standalone Note: practice numbers refer to those at the end of the Financial Year Fee income refers to the fees charged by Pets at Home to First Opinion Joint Venture practices operating within the Group. 2. Other veterinary income includes, but is not restricted to, the consolidated revenues from a small number of wholly owned First Opinion practices within the Group. These practices act mainly as trial businesses for potential Joint Venture Partners. Vet Group Business Summary 3
5 First Opinion Joint Venture business model We operate a franchise-like partnership, where practices are partly owned and managed by Joint Venture Partners (JVPs), who are mostly veterinary practitioners. The JVPs run the practice, employ other veterinarians and make all the clinical decisions. Pets at Home arranges financing for the setup and ongoing operations of the practice, and provides business support services such as accounting, marketing, IT and procurement. This structure allows JVPs to do what they do best providing the best standards of clinical care. All our practices are opened as brand new premises, with ownership shared between the JVP and Pets at Home. To finance the setup of the practice and the early years cashflow requirements, we arrange a loan from a third party commercial bank, alongside small loans direct from Pets at Home and the JVP. Pets at Home may also directly provide additional funding to the practice through its lifetime if required, in the form of operating loans. JVP Salary c 40-50,000 Dividend c 70-80,000 Practice revenue c 1m+ Fee income c 180,000+ Financing, repaid as the Clinical expertise Business support services practice matures The JVP manages the day to day operations and is entitled to the profit in the business after all loans have been repaid. Partners are also entitled to the capital value of the business if they wish to sell the practice. Pets at Home receives fee income, which is c17-18% of the practice s revenue, in return for which we provide business support services through our colleagues at the Support Office. c 30,000 JVP loan c ,000 loan Commercial bank c 30-60,000 corporate loan Up to c ,000 additional operating loans if required Note: Representative of an average, mature, debt free Joint Venture practice when all funding loans are repaid. Vet Group Business Summary 4
6 Specialist Referral Shared Venture business model Specialist Referral centres are considerably larger than First Opinion practices. They are multi disciplinary units that handle complex veterinary medicine. Recognising the strength of our Joint Venture model in First Opinion, we developed a shared ownership model in Specialist Referrals, which not only allows the vets or Directors to retain a significant interest in the business, it also supports future growth and clinical development. up to 25% equity owned by key clinicians or Directors Accounting treatment of veterinary Specialist Referral centres Three of our four centres are structured as a Shared Venture ownership model, where Pets at Home maintains a minimum 75% controlling share, with the remaining shares owned by multiple clinician Shared Venture Partners (SVPs). As such, the practice income statements, balance sheets and cashflows are fully consolidated. Specialist Referral Centres Pets at Home has an option to buy the SVP s shares in the future, with the value of these shares related to profit performance targets. The accounting treatment of such an option is therefore structured as a forward contract. Within the income statement, the discounted future value of the SVP s shares is recognised as an expense over the period to which the option can be exercised, and recognised as an non-underlying expense. 75%+ equity owned by Pets at Home Vet Group Business Summary 5
7 Our shared ownership models create loyalty and incentivise future growth First Opinion practices Specialist Referral Centres Typical number of Joint Venture Partners (JVPs) / practice One JVP share of practice dividend when loans repaid 100% Typical number of Shared Venture Partners (SVPs) / practice Multiple SVP share of practice dividend 5-25% Equity / capital value entitlement JVP has 100% Typical timeframe JVP chooses to sell the practice 10 years + Equity / capital value entitlement SVP clinicians have up to 25% Typical timeframe SVP chooses to sell their share Minimum 4 years Day to day management and influence Managed by the JVP. Pets at Home provides business services Day to day management and influence SVP & Referral Centre colleagues run the day to day operations and are managed by the Pets at Home Vet Group Vet Group Business Summary 6
8 Appendix: Additional information on the First Opinion Joint Venture vet business Vet Group Business Summary 7
9 Vet Group Business Summary 8 Avg Revenue Avg PBT Avg fee income to PAH <1 year 1-2 years 3-4 years 5-6 years 7-9 years 10+ years Our vet practices are all startup businesses, where it takes a number of years to steadily build a client list and reach breakeven profitability. Practices will typically begin to generate a pre-tax profit at around 4-5 years old. The speed at which the practice matures and reaches profitability influences the rate at which the JV Partner can repay the initial funding loans and subsequently begin to receive dividends. Pets at Home receives fee income as a proportion of the practice s revenue, which is up to 60,000 per annum in the first two years of opening, and can reach c 180,000 per annum from a mature practice. 1,000 1,200 Revenue and PBT profiles of JV practices There is a long term maturity profile in our vet practices
10 Our mature practices outperform the wider market, with strong returns for our vet partners We have 87 mature, debt free practices Generating combined practice turnover of 89m and combined PBT of 12m Our mature JV practices Vs. corporate competitors Average practice turnover c 1,000k c k Average practice PBT c k c k JVP base salary + bonus c 40-50k c 60-90k (Clinical Director) c 40-60k (mid career vets) Dividend payments to JVP (practice may have >1 JVP receiving dividends c 70-80k N/A Capital value to JVP at exit c 500k- 1,000k+ N/A Note: Mature debt-free practices defined as those that have paid down initial bank loan, personal and Pets at Home funding (incl. any operating loan) Sources: PAHVG Financials; PAH estimates based on publicly available filings of four other large UK corporate vet groups (IVC, CVS, VetPartners and Medivet) Vet Group Business Summary 9
11 We have a young vet practice estate, where over half of practices have been opened in the past four years Age of vet practice estate 10 years + 16% 5-9 years 28% 0-4 years 56% Vet Group Business Summary 10
12 Registered Office Pets at Home Group Plc Epsom Avenue Stanley Green Trading Estate Handforth Cheshire SK9 3RN United Kingdom Investor Relations Enquiries Amie Gramlick Director of Investor Relations t: +44 (0) investors.petsathome.com
Investor presentation. September 2018
Investor presentation September 2018 Forward looking statements Forward-Looking Statements INCLUDED IN THIS PRESENTATION ARE FORWARD-LOOKING MANAGEMENT COMMENTS AND OTHER STATEMENTS THAT REFLECT MANAGEMENT
More informationBecoming the best pet care business in the world. Strategic update and interim financial results FY19
Becoming the best pet care business in the world Strategic update and interim financial results FY19 Interim Results FY19 2 Today s presentation Group strategic update and vet business review Financial
More informationPreliminary Results FY17
Preliminary Results FY17 25 th May 2017 Forward looking statements Forward-Looking Statements INCLUDED IN THIS PRESENTATION ARE FORWARD-LOOKING MANAGEMENT COMMENTS AND OTHER STATEMENTS THAT REFLECT MANAGEMENT
More informationPets at Home Group Plc: Preliminary Results FY17
FOR IMMEDIATE RELEASE, 25 MAY 2017 Pets at Home Group Plc: Preliminary Results FY17 Pets at Home Group Plc, the UK s leading specialist retailer of pet food, accessories, veterinary and grooming services,
More informationPets At Home Group Plc
FOR IMMEDIATE RELEASE, 11th NOVEMBER 2014 Pets At Home Group Plc Pets At Home Group Plc, the UK s leading specialist retailer of pet food, accessories, petrelated products and services, today issues prior
More informationInterim Results FY18 28 th November 2017
Interim Results FY18 28 th November 2017 Forward looking statements Forward-Looking Statements INCLUDED IN THIS PRESENTATION ARE FORWARD-LOOKING MANAGEMENT COMMENTS AND OTHER STATEMENTS THAT REFLECT MANAGEMENT
More informationPets At Home Group Plc: Interim Financial Results FY15
FOR IMMEDIATE RELEASE, 4 DECEMBER Pets At Home Group Plc: Interim Financial Results FY15 Delivering on the strategic plan across all measures Pets At Home Group Plc, the UK s leading specialist retailer
More informationFOR IMMEDIATE RELEASE, 27th NOVEMBER 2018 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
FOR IMMEDIATE RELEASE, 27th NOVEMBER 2018 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION Becoming the leading pet care specialist and returning to sustainable cashflow growth: interim financial results,
More informationCVS Group plc. Final Results Year to 30 June September 2009
CVS Group plc Final Results Year to 30 June 2009 September 2009 Highlights Revenue growth + 23% EBITDA (adjusted) growth + 30% PBT (adjusted) growth + 53% EPS (adjusted) growth + 44% 12.4m of cash generated
More informationnemo2014\presentations\analyst Presentation Jan14\ Nemo Analyst Presentation Master-22nd Jan FINAL.pptx
Interim Results FY17 24 th November 2016 Forward looking statements Forward-Looking Statements INCLUDED IN THIS PRESENTATION ARE FORWARD-LOOKING MANAGEMENT COMMENTS AND OTHER STATEMENTS THAT REFLECT MANAGEMENT
More informationCVS Group plc Annual results for the year ended 30 June Your pets, our priority
CVS Group plc Annual results for the year ended 30 June 2014 Simon Innes Chief Executive Officer Nick Perrin Finance Director Highlights Strategy Business review - Practices - Laboratories - Animed Direct
More informationCVS Group plc. Final Results Year to 30 June October 2010
CVS Group plc Final Results Year to 30 June 2010 October 2010 Index Highlights 3 Appendices Overview of CVS 4 Financial Highlights 5 Margin Analysis 22 Profit & Loss 6 Debt Repayment 23 Cashflow 7 Bank
More informationHome of all things pet. Pets at Home Group Plc Annual Report and Accounts 2018
Home of all things pet Pets at Home is the UK s leading pet care company Strategy and performance Delivering our strategy supports growth across like-for-like revenues, space rollout and margins. Page
More informationCVS Group plc Interim results for the 6 months ended 31 December Simon Innes Chief Executive Officer Nick Perrin Finance Director
CVS Group plc Interim results for the 6 months ended 31 December 2016 Simon Innes Chief Executive Officer Nick Perrin Finance Director Highlights Industry update Business review - Practices - Laboratories
More informationFinancial statements. Pets at Home Group Plc Annual Report and Accounts 2018
Financial statements Independent Auditor s Report 103 Consolidated income statement 108 Consolidated statement of comprehensive income 108 Consolidated balance sheet 109 Consolidated statement of changes
More informationCVS Group plc. Full Year Results 30 June September 2012
CVS Group plc Full Year Results 30 June 2012 September 2012 Highlights Revenue growth Like-for-Like Sales + 2.9% EBITDA (adjusted) Operating profit + 7.1% to 108.7m + 7.9% to 15.7m + 6.7% to 6.8m EPS (adjusted)
More informationOperational Highlights. Share Price Performance. Integration of portfolio
nvcltd.com.au O V E R V I E W Operational Highlights Share Price Performance Integration of portfolio Implementation of initiative(s) 11 acquisitions settled from Jul 1 st 2016 to Feb 27 th 2017. 2 new
More informationTrupanion Investor Presentation. March 2017
Trupanion Investor Presentation March 2017 Legal Disclaimers This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
More informationNASDAQ: HSIC Q1 2018
NASDAQ: HSIC Q1 2018 Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information Safe Harbor Provision Forward Looking Statements In accordance with the "Safe Harbor"
More informationNASDAQ: HSIC Q3 2017
NASDAQ: HSIC Q3 2017 Safe Harbor Provision Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information In accordance with the "Safe Harbor" provisions of the Private
More informationInformation Memorandum
centre centre Shailen Jasani MA Vet MB MRCVS DACVECC Iqbal Dhanji MBA BSc FCA Co-Founders and Directors The Ralph Veterinary Referral Centre PLC An Enterprise Investment Scheme ( EIS ) Investment Opportunity
More informationNASDAQ: HSIC Q3 2018
NASDAQ: HSIC Q3 2018 Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information Safe Harbor Provision Forward Looking Statements In accordance with the "Safe Harbor"
More informationFull Year Results Year Ending June 2017 National Veterinary Care Ltd. nvcltd.com.au
Full Year Results Year Ending June 2017 National Veterinary Care Ltd. nvcltd.com.au Important Notice and Disclaimer Future Statements Except for historical information, there may be matters in this presentation
More informationTrupanion Investor Presentation. September 2017
Trupanion Investor Presentation September 2017 Legal Disclaimers This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of
More informationHENRY SCHEIN TO SPIN OFF AND MERGE ITS ANIMAL HEALTH BUSINESS WITH VETS FIRST CHOICE, CREATING AN INNOVATIVE APPROACH TO ADVANCING VETERINARY CARE
HENRY SCHEIN TO SPIN OFF AND MERGE ITS ANIMAL HEALTH BUSINESS WITH VETS FIRST CHOICE, CREATING AN INNOVATIVE APPROACH TO ADVANCING VETERINARY CARE APRIL 23, 2018 Safe Harbor Statement Forward Looking Statements
More informationTrupanion Investor Presentation. February 2018
Trupanion Investor Presentation February 2018 Legal Disclaimers This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of
More informationBIOCON GROUP F A C T S H E E T
BIOCON GROUP F A C T S H E E T March - 2017 BALANCE SHEET (Rs Cr) March 31, 2017 March 31, 2016 ASSETS Non-current assets (a) Property, plant and equipment 3,553 1,681 (b) Capital work-in-progress 533
More informationGroup results 2014/15 (on a continuing operations basis) On a continuing operations basis 2014/15
Financial review The reported year has been both an extremely challenging year for Tesco and a year in which we began a process of considerable change. Against this backdrop we delivered sales of 70bn
More informationSafe Harbor Provision
Q2 2016 Safe Harbor Provision Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information In accordance with the "Safe Harbor" provisions of the Private Securities Litigation
More informationQ4 FY 2013 Earnings Update. Q2 FY 2013 Earnings Update
1 Q4 FY 2013 Earnings Update Q2 FY 2013 Earnings Update Safe Harbour No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness
More informationBALBOA VETERINARY MEDICAL CENTER
BALBOA VETERINARY MEDICAL CENTER OWNER INFORMATION First Name Last Name Spouse/Other Address City State Zip Code Home Phone Cell Phone #1 Work Phone Cell Phone #2 *Email Client's D.O.B Drivers License
More informationCorporate Presentation 6 months ended 30 June Page 0
Corporate Presentation 6 months ended 30 June 2018 Page 0 This presentation has been prepared by the Company and its contents have been reviewed by the Company s sponsor, PrimePartners Corporate Finance
More information#thisiscvs. CVS Group plc Annual Report for the year ended 30 June 2017
#thisiscvs CVS Group plc Annual Report for the year ended 30 June #thisiscvs Strategic report 1 Financial highlights 2 CVS at a glance 4 Chairman s statement 6 Our business model 8 Our strategy 10 Key
More informationFull year results to 31 December Morgan Sindall Group plc 22 February 2018
Full year results to 31 December 2017 Morgan Sindall Group plc 22 February 2018 Agenda Introduction John Morgan FY 2017 Financial and Operational Review Steve Crummett Investments John Morgan 2 Summary
More informationFranchising IVF and the Changing Business Model for Laboratory Operations
Franchising IVF and the Changing Business Model for Laboratory Operations Richard T. Scott, Jr, MD, HCLD/ALD CEO, IVI RMA Global Clinical and Scientific Director, IVI RMA New Jersey Professor and Director,
More informationAnnual Review 2013/14
Litigation Authority Annual Review 2013/14 Forward Look for 2014/17 & Catherine Dixon Chief Executive, NHS Litigation Authority Welcome to the NHS LA s Annual Review for 2013/14 and Forward Look for the
More informationInvestment in Botswana. Letsebe Sejoe Chief Executive Officer (A) August, 2013
Investment in Botswana Letsebe Sejoe Chief Executive Officer (A) August, 2013 Contents 1. BITC mandate 2. Investment, Trade & Export Promotion 3. Investment Opportunities 4. Incentives for Investment Attraction
More informationEvidence Based Practice Management
Evidence Based Practice Management Growing Your Business Like a Doc Melissa Maddux, DVM Chief Innovative Human Patient Health Evidence Based Medicine + Practice Health Evidence Based Practice Management
More informationNew for 2019! DHDR has partnered with several pet insurance companies to offer you, our adopters, a variety of coverage options.
Pet Insurance Discounts New for 2019! DHDR has partnered with several pet insurance companies to offer you, our adopters, a variety of coverage options. Embrace o 5% discount on their premiums. Be sure
More informationFY 2015 Results Presentation. 19 January 2016
FY 2015 Results Presentation 19 January 2016 Disclaimer THIS PRESENTATION IS NOT AN OFFER OR SOLICITATION OF AN OFFER TO BUY OR SELL SECURITIES IN THE UNITED STATES OF AMERICA OR IN ANY OTHER JURISDICTION.
More informationCVS Group plc. Annual Results For the year ended 30 June Prepared for: Simon Innes Chief Executive Officer Nick Perrin Finance Director
CVS Group plc Annual Results For the year ended 30 June 2017 Simon Innes Chief Executive Officer Nick Perrin Finance Director Prepared for: Agenda Highlights Strategy Business Review - Practices - Laboratories
More informationInsurance Claims Do you have insurance? We offer Indirect and Direct Claims
Insurance Claims Do you have insurance? We offer Indirect and Direct Claims Indirect Claims When your insurance company reimburses you directly These are also called policy claims and you need to send
More informationFinancial Highlights
For Immediate Release 27 September 2018 CVS GROUP plc ( CVS, the Company or the Group ) Preliminary Results for the year ended 30 June 2018 CVS, one of the UK s leading providers of veterinary services,
More informationCVS Group plc ANNUAL REPORT
Your pets, our priority CVS Group plc ANNUAL REPORT for the year ended 30 June Registered number: 06312831 1 CVS Group plc Annual Report ANNUAL REPORT for the year ended 30 June CVS Group plc owns 252
More informationJune 2015 NASDAQ: RDNT
June 2015 NASDAQ: RDNT Safe Harbor This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning
More information1 30/05/2018 AG Employee Benefits - Trust in Expertise. Bonus Plan
1 30/05/2018 AG Employee Benefits - Trust in Expertise Bonus Plan Your Bonus Plan: a Tax-Efficient Way to Reward your Employees Sample Case Comparison based on a gross bonus payment of EUR 10,000 paid
More informationSavills plc. Preliminary results for the year ended 31 December 2009
Savills plc Preliminary results for the year ended 31 December 1 Disclaimer Forwardlooking statements These slides contain certain forwardlooking statements including the Group s financial condition, results
More informationJ SAINSBURY PLC (THE COMPANY ) ANNUAL REPORT AND FINANCIAL STATEMENTS 2016
3 June 2016 J SAINSBURY PLC (THE COMPANY ) ANNUAL REPORT AND FINANCIAL STATEMENTS 2016 The following documents have today been posted or otherwise made available to shareholders: Annual Report and Financial
More informationVCA ANTECH INC. FORM 10-K (Annual Report) Filed 3/1/2007 For Period Ending 12/31/2006
VCA ANTECH INC FORM 10-K (Annual Report) Filed 3/1/2007 For Period Ending 12/31/2006 Address 12401 WEST OLYMPIC BOULEVARD LOS ANGELES, California 90064-1022 Telephone 310--58-4-65 CIK 0000817366 Industry
More informationAIM Inheritance Tax Portfolio
AIM Inheritance Tax Portfolio Aiming to reduce your inheritance tax bill For those investors prepared to accept the additional risks of investing in AIM, there are tax benefits. AIM stocks are free of
More informationASX Announcement (ASX: PRY)
ASX Announcement (ASX: PRY) ASX Limited Market Announcements Office Exchange Centre Level 4, 20 Bridge Street Sydney NSW 2000 ACN 064 530 516 REGISTERED OFFICE: LEVEL 6 203 PACIFIC HIGHWAY ST LEONARDS
More informationFINANCIAL STATEMENTS AND INDEPENDENT AUDITORS REPORT FLORIDA VETERINARY MEDICINE FACULTY ASSOCIATION, INC. GAINESVILLE, FLORIDA JUNE 30, 2017
FINANCIAL STATEMENTS AND INDEPENDENT AUDITORS REPORT FLORIDA VETERINARY MEDICINE FACULTY ASSOCIATION, INC. GAINESVILLE, FLORIDA JUNE 30, 2017 FINANCIAL STATEMENTS AND INDEPENDENT AUDITORS REPORT FLORIDA
More informationFY 2018 RESULTS YEAR ENDED 30 JUNE 2018
FY 2018 RESULTS YEAR ENDED 30 JUNE 2018 PRIMARY S VISION 2 EVENT TITLE TEXT HERE PRIMARY S VISION» Healthcare in Australia largely unchanged for decades» At a watershed with costs, technology and choice
More informationInterim Report for the six months to 31st December Stock Code: ANCR. Veterinary Products for Companion Animals
Interim Report for the six months to Veterinary Products for Companion Animals Animalcare Group plc Interim Report Animalcare Group plc is focused on growing its veterinary business. Animalcare is a leading
More informationInvestor presentation
Investor presentation Important information Forward-Looking Statements and Risks & Uncertainties This document and the related oral presentation contain, and responses to questions following the presentation
More informationInvestor Presentation. August 2006
Investor Presentation August 2006 Forward-Looking Statements This presentation contains forward-looking statements that are subject to risks and uncertainties including, but not limited to, the impact
More informationLiberty Tax, Inc. I n v e s t o r P r e s e n t a t i o n
Liberty Tax, Inc. I n v e s t o r P r e s e n t a t i o n Safe Harbor Statement This presentation may contain forward-looking statements within the meaning of the securities laws. Forwardlooking statements
More informationLOOKERS plc. Annual Results for the year ended 31 December 2017
LOOKERS plc Annual Results for the year ended 31 December 2017 Solid underlying growth in a challenging market, with increased dividend and share buyback plan announced Lookers plc, ( Lookers, the company
More informationPaper P7 (IRL) Advanced Audit and Assurance (Irish) Monday 1 December Professional Level Options Module
Professional Level Options Module Advanced Audit and Assurance (Irish) Monday 1 December 2014 Time allowed Reading and planning: Writing: 15 minutes 3 hours This paper is divided into two sections: Section
More informationPreliminary Results March Fyffes plc
10 March 2014 Fyffes plc Fyffes overview Operates in the international tropical produce sector - Product categories bananas, pineapples, melons - Areas of activity Europe, US, Central & South America Market
More information2017 Results Presentation.
2017 Results Presentation www.moelisaustralia.com 20 February 2018 Moelis Australia Overview Moelis Australia is a leading diversified financial services group incorporating Corporate Advisory, Equities
More informationInsure Egypt
Bancassurance in Practice Munich Re Introduction One of the most significant changes in the financial services sector over the past few years has been the appearance and development of bancassurance. Banking
More informationFINANCIAL STATEMENTS AND INDEPENDENT AUDITORS REPORT FLORIDA VETERINARY MEDICINE FACULTY ASSOCIATION, INC. GAINESVILLE, FLORIDA JUNE 30, 2018
FINANCIAL STATEMENTS AND INDEPENDENT AUDITORS REPORT FLORIDA VETERINARY MEDICINE FACULTY ASSOCIATION, INC. GAINESVILLE, FLORIDA JUNE 30, 2018 FINANCIAL STATEMENTS AND INDEPENDENT AUDITORS REPORT FLORIDA
More informationCorporate Presentation 9 months ended 30 September Page 0
Corporate Presentation 9 months ended 30 September 2018 Page 0 This presentation has been prepared by the Company and its contents have been reviewed by the Company s sponsor, PrimePartners Corporate Finance
More informationPremium Franchise Package
We Care Premium Franchise Package Premium Package only $26,170 plus... $14,730 - The Aussie Pooch Mobile Dog Wash Unit & Equipment. Ask about Second hand and rent to buy options on your Aussie Pooch Mobile
More informationSCALES CORPORATION LIMITED GROWING YOUR DIVERSIFIED AGRIBUSINESS
SCALES CORPORATION LIMITED GROWING YOUR DIVERSIFIED AGRIBUSINESS Acquisition of 60% stake in Shelby JV LLC 14 TRANSACTION OVERVIEW Scales has today announced the acquisition of a 60% interest in Shelby
More informationAugust 2018 Trupanion Investor Presentation
August 2018 Trupanion Investor Presentation This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange
More informationSKYCITY Entertainment Group Limited. FY16 Full-Year Result Presentation 10 August SKYCITY Entertainment Group Limited
SKYCITY Entertainment Group Limited FY16 Full-Year Result Presentation 10 August 2016 SKYCITY Entertainment Group Limited Disclaimer All information included in this presentation is provided as at 10 August
More informationFY2017 Earnings presentation. Landis+Gyr June 5, 2018
FY2017 Earnings presentation Important notices This presentation includes forward-looking information and statements including statements concerning the outlook for our businesses. These statements are
More informationMonash University Policy. Deputy Vice Chancellor, Vice-President (Resources) Deputy Vice Chancellor (Resources) POLICY STATEMENT
Monash University Policy Policy Title Insider Trading Policy Date Effective 18/12/2000 Review Date Policy Owner Category Deputy Vice Chancellor, Vice-President (Resources) Operational Version Number Content
More informationEquine. 100% Reinsured by certain underwriters at Lloyds of london
Tailored BREED Protection Equine I N S U R A N C E 100% Reinsured by certain underwriters at Lloyds of london TAILORED equine PROTECTION Policy BEnefitS Equine Insurance: Whether you depend on your stable
More informationFY16 YEAR END RESULTS 5 APRIL 2016
FY16 YEAR END RESULTS 5 APRIL 2016 DEFINITIONS AND IMPORTANT NOTICE The following definitions apply throughout Trading EBITDA (earnings before interest, tax, depreciation and amortisation): excludes exceptional
More informationCareCore National Musculoskeletal Management Program Physical Medicine and Therapy Frequently Asked Questions
EVIDENCE-BASED HEALTHCARE SOLUTIONS CareCore National Physical Medicine and Therapy Prepared for December 2, 2014 Table of Contents Introduction to CareCore National... 3 Who is CareCore National?... 3
More informationUpdate: 31/01/14, EN. Panel Statistics
Update: 31/01/14, EN Panel Statistics Content Introduction...3 1. Germany: Overview...4 2. Germany: Human medicine...5 2.1 Distribution by professional group: Physicians with private practices vs. clinicians...
More informationNovember 2017 NASDAQ: RDNT
November 2017 NASDAQ: RDNT Safe Harbor This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning
More informationFor personal use only
Replacement Prospectus For the offer of 30.0 million Shares at an Offer Price of $1.00 per Share to raise $30.0 million. The Offer is underwritten by Shaw and Partners Corporate Finance Pty Limited and
More informationThe UK s most comprehensive and integrated provider of veterinary services to animal owners
CVS Group plc Annual Report for the year ended 30 June The UK s most comprehensive and integrated provider of veterinary services to animal owners 363 veterinary practices, four diagnostic laboratories,
More informationH1 16 interim results. 22 September 2015
H1 16 interim results 22 September 2015 Important notice 2 This presentation may include certain forward-looking statements, beliefs or opinions, including statements with respect to the Company s business,
More informationDomino s Pizza UK & IRL plc. Interim Results for the 26 weeks ended 28 June 2009
Domino s Pizza UK & IRL plc Interim Results for the 26 weeks ended 28 June 2009 m System sales momentum 210 System sales have doubled since 2005 196.4 190 170.2 170 150 130 110 97.1 114.8 142.5 +24.1%
More informationTHREE-YEAR STRATEGY Centrum Medyczne ENEL-MED S.A.
THREE-YEAR STRATEGY Centrum Medyczne ENEL-MED S.A. AREAS OF BUSINESS ACTIVITY Subscriptions 57% revenues Commercial and insurance services at outpatient clinics 15% revenues Diagnostic imaging 16% revenues
More informationHeritage Foods Limited Financial Results Q3FY17 Hyderabad, 24 th January 2017
Heritage Foods Limited Financial Results Q3FY17 Hyderabad, 24 th January 2017 Stock Code: BSE: 519552 NSE: HERITGFOOD REUTERS: HEFI.BO / HEFI.NS BLOOMBERG: HTFL IN Quarterly Update Disclaimer The release
More informationQ3 FY 2013 Earnings Update. Q2 FY 2013 Earnings Update
1 Q3 FY 2013 Earnings Update Q2 FY 2013 Earnings Update Safe Harbour No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness
More informationCOMPANY REGISTRATION NUMBER CV PHARMA LIMITED CONSOLIDATED ACCOUNTS AND FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED
COMPANY REGISTRATION NUMBER 03697835 CV PHARMA LIMITED CONSOLIDATED ACCOUNTS AND FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 30th JUNE 2018 CONSOLIDATED ACCOUNTS AND FINANCIAL STATEMENTS CONTENTS
More informationBUY. FY17 a blip; gradual recovery ahead APOLLO HOSPITALS ENTERPRISE. Target Price: Rs 1,472
FY17 a blip; gradual recovery ahead Apollo Hospital s FY17 earnings miss (EBITDA at Rs 7.3 bn vs. our expectation of Rs 7.8 bn) was largely due to lower than expected margin in matured hospitals. Stent
More informationJefferies 2014 Global Healthcare Conference June 2, 2014
Jefferies 2014 Global Healthcare Conference June 2, 2014 Safe Harbor Provision In accordance with the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, we provide the following
More informationFor personal use only
APPENDIX 4E Cash Converters International Limited ABN: 39 069 141 546 Financial year ended 30 June 2015 RESULTS FOR ANNOUNCEMENT TO THE MARKET 30 June 2015 30 June 2014 Revenues from operations Up 13.0%
More informationSupporting NHS providers: guidance on merger benefits
www.gov.uk/monitor Supporting NHS providers: guidance on merger benefits About Monitor As the sector regulator for health services in England, our job is to make the health sector work better for patients.
More informationTurnover (see note 2) 8, , , , Operating profit (see note 3) (26.5) (72.0) 471.0
Consolidated profit and loss account 52 weeks ended 53 weeks ended 1 April 2000 Before After Before After exceptional Exceptional exceptional exceptional Exceptional exceptional items items items items
More informationFinancial and Operational Review
Financial and Operational Review For the year ended 30 June 2018 Colin Goldschmidt CEO, Sonic Healthcare 16 August 2018 Forward-looking statements This presentation may include forward-looking statements
More informationChief Financial Officer s Report Jonny Mason
Chief Financial Officer s Report Jonny Mason Financial Resources Generating returns for our stakeholders through effective management of our financial resources. Group revenue in, at 1,135.1m, was up 3.7%
More informationPolicies, Terms and Conditions
4425-C Treat Blvd #330 Concord, Ca 94521 (925) 899-7354 info@vettechpetcare.com Policies, Terms and Conditions For the purposes of this document, the terms Client, Owner, Pet Owner, and Customer are synonymous
More informationThe UK s most comprehensive and integrated provider of veterinary services to animal owners
CVS Group plc Annual Report for the year ended 30 June The UK s most comprehensive and integrated provider of veterinary services to animal owners 298 veterinary surgeries, 5 diagnostic laboratories, 4
More informationGREGGS TO RESHAPE BUSINESS FOR FUTURE GROWTH
6 August 2013 INTERIM RESULTS FOR THE 26 WEEKS ENDED 29 JUNE 2013 AND STRATEGY UPDATE Greggs is the leading bakery retailer in the UK, with close to 1,700 shops throughout the country GREGGS TO RESHAPE
More informationCompany Overview. Financial Performance
Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 CMP: 43.00 January 11, 2015 Stock Details BSE code 526301 BSE ID MEDINOV Face value ( ) 10 No of shares (m) 9 52 week
More informationMAISONS DU MONDE: FULL-YEAR 2018 RESULTS
PRESS RELEASE MAISONS DU MONDE: FULL-YEAR 2018 RESULTS Strong performance in line with targets Continued solid momentum in online and international sales Focus on strategic pillars to deliver further profitable
More informationAnnual Report 2017 Contents. Contents
Annual Report 2017 Annual Report 2017 Contents Contents CEO statement 2017............................................ 3 Administration Report......................................... 5 Income Statement,
More informationYEAR END RESULTS 31 MARCH Russell Down, Chief Executive Chris Morgan, Group Finance Director
YEAR END RESULTS 31 MARCH 2018 Russell Down, Chief Executive Chris Morgan, Group Finance Director Customer service strategy improving performance Revenue (excluding disposals) 371.6m 6.4% FY17: 349.1m
More informationQ1 FY 2018 Earnings Update. 8/14/2017
Q1 FY 2018 Earnings Update 1 SAFE HARBOUR No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the
More informationCorporate Presentation 3 months ended 31 March Page 0
Corporate Presentation 3 months ended 31 March 2017 Page 0 This presentation has been prepared by the Company and its contents have been reviewed by the Company s sponsor, PrimePartners Corporate Finance
More informationFinal results for 52 weeks to 27 December Ralph Topping, Chief Executive Neil Cooper, Group Finance Director
Final results for 52 weeks to 27 December 2011 Ralph Topping, Chief Executive Neil Cooper, Group Finance Director 1 Agenda Overview Ralph Topping, Chief Executive Financial highlights Neil Cooper, Group
More information